November 14, 2023
The Future Will Look Like The Past
Not a day goes by without someone asking me who the third player will be in the CGM market. It won’t be Senseonics nor will be it be Medtronic the two companies besides Dexcom and Abbott to have an FDA approved sensor. Implantable is a bad business model and Medtronic is clueless. And let’s state up front we do not care who has a CE mark it’s FDA approval that matters.
Let’s also make it clear that non-invasive is a pipe dream and quite frankly isn’t even needed. Non-invasive is solution looking . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
